Oral CancerNCT01424358
Web-based Education on Oral Cancer for Primary Care Physicians in Ohio
A study testing Web-based Educational Intervention in people with Oral Cancer, run by Creighton University at 1 site in United States.
Trial summary
Objective: The experimental design is a one-site, randomized experimental web-based educational feasibility intervention trial, with approximately 50% primary care physicians (PCPs) in the intervention group and approximately 50% PCPs on the control group, giving a total of 159 participants. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Oral Cancer
- What is being tested?
- Web-based Educational Intervention
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 10 participants
- Where
- 1 siteUnited States
- Study dates
- Jul 2011to Sep 2013
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- The PCP's who participated in Specific Aim #2 (Survey of Healthcare Professionals on Oral Cancer in Ohio ) of the NIH K23 grant proposal, "Intervention to Prevent Delayed Diagnosis of Oral Cancer", will be eligible to participate in this Web-Based Education on Oral Cancer.
- Possessing the ability to give voluntary consent to participate. Participating in the web-based educational intervention is am implication of consent.
- All participants are expected to be relatively healthy.
Who cannot join
- Unable to have access to the internet to be able to participate in the web-based education.
Trial locations and contacts
1 site in 1 country.
United States1 site
Creighton University School of Dentistry
Omaha, Nebraska, 68178
About this study
Objective:
The experimental design is a one-site, randomized experimental web-based educational feasibility intervention trial, with approximately 50% primary care physicians (PCPs) in the intervention group and approximately 50% PCPs on the control group, giving a total of 159 participants. All 159 participants have willingly provided their e-mail addresses, as part of a survey they previously completed entitled, "Survey of Health Professionals on Oral Cancer in Ohio- Intervention to Prevent Delayed Diagnosis of Oral Cancer."
Read the detailed description
The main specific aim is to determine the short-term effectiveness of a web-based educational intervention for primary care physicians (PCPs) in Ohio to improve the following:Index of knowledge of risk factors for oral cancer, and Index of knowledge of diagnostic procedures for oral cancer
The following hypothesis will be explored: The use of a web-based educational module for PCPs in Ohio regarding oral cancer will increase the proportion of the PCPs in the high score category for the following indices: Index of knowledge of risk factors of oral cancer, and Index of knowledge of diagnostic procedures for oral cancer
- Conditions
- Oral Cancer
- Being tested
- Web-based Educational Intervention
- Medical subject headings
- Mouth Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Web-based Educational InterventionOther
The intervention group will be invited to participate in the web-based educational program. PCPs in the intervention group will be asked to view the educational module which will be followed by an assessment. This group will be tested on the following knowledge outcomes: Index of knowledge of risk factor for oral cancer and Index of knowledge of diagnostic procedures for oral cancer.
| Study group | Role | What they receive |
|---|---|---|
| Web-based Educational | Experimental | Not described Receives: Other: Web-based Educational Intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Index of knowledge of diagnostic procedure for oral cancer
The list of participants will be sent an initial email inviting them to view the module and complete a pre test (control group) or a post test (intervention group). Reminder emails will be sent every 2 months for up to 6 months following the initial email. It is expected that at least a 15% higher proportion of Intervention group PCPs will attain the high score category for each of this index, as compared to the Control group PCPs.
Measured: An average of 8 months from the time of the initial email sent on 7/21/11.
Secondary outcomes (2)
To determine if a change in Stage of Diagnosis of Oral Cancer occurred for the particular year of Web-based Educational Intervention.
Three years post-web-based education intervention data will be requested from Ohio Cancer Incidence Surveillance System (OCISS). OCISS's cleaning and processing of the data takes approximately three years. Comparison using Chi-square will be carried out pre- and post- intervention years.
Measured: 3 years
Index of knowledge of risk factors for oral cancer.
The list of participants will be sent an initial email inviting them to view the module and complete a pre test (control group) or a post test (intervention group). Reminder emails will be sent every 2 months for up to 6 months following the initial email. It is expected that at least a 15% higher proportion of Intervention group PCP's will attain the high score category for this index, as compared to the Control group PCP's.
Measured: An average of 8 months from the time of the initial email sent on 7/21/11.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Aug 2011 (estimated)
- Study startJul 2011
- Primary completionSep 2013
- Study completionSep 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (8)Papers the sponsor has linked to this study.
- Other trials for Oral CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 10 participants (actual)
Sponsor and investigators
- Lead sponsor
- Creighton University
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute of Dental and Craniofacial Research (NIDCR)
- Responsible party
- Sponsor
- Investigators
- Alvin G Wee, DDS, MS, MPH, Principal investigator, Creighton University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01424358
- Sponsor's protocol ID
- 11-16008
- Other IDs
- 7K23DE016890-07
- Status last verified
- Dec 2012
- First submitted
- 22 Aug 2011
- Last updated
- 24 Mar 2015
- Results posted
- No
- Data monitoring committee
- No
Publications
Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002 Jan-Feb;52(1):23-47. doi: 10.3322/canjclin.52.1.23.
PubMed 11814064Canto MT, Devesa SS. Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998. Oral Oncol. 2002 Sep;38(6):610-7. doi: 10.1016/s1368-8375(01)00109-9.
PubMed 12167440Silverman S Jr. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc. 2001 Nov;132 Suppl:7S-11S. doi: 10.14219/jada.archive.2001.0382.
PubMed 11803655Mashberg A, Garfinkel L. Early diagnosis of oral cancer: the erythroplastic lesion in high risk sites. CA Cancer J Clin. 1978 Sep-Oct;28(5):297-303. doi: 10.3322/canjclin.28.5.297. No abstract available.
PubMed 100189Horowitz AM, Nourjah PA. Factors associated with having oral cancer examinations among US adults 40 years of age or older. J Public Health Dent. 1996 Fall;56(6):331-5. doi: 10.1111/j.1752-7325.1996.tb02460.x.
PubMed 9089528Canto MT, Drury TF, Horowitz AM. Use of skin and oral cancer examinations in the United States, 1998. Prev Med. 2003 Sep;37(3):278-82. doi: 10.1016/s0091-7435(03)00124-5.
PubMed 12914834Horowitz AM, Moon HS, Goodman HS, Yellowitz JA. Maryland adults' knowledge of oral cancer and having oral cancer examinations. J Public Health Dent. 1998 Fall;58(4):281-7. doi: 10.1111/j.1752-7325.1998.tb03010.x.
PubMed 10390710Goodman HS, Yellowitz JA, Horowitz AM. Oral cancer prevention. The role of family practitioners. Arch Fam Med. 1995 Jul;4(7):628-36. doi: 10.1001/archfami.4.7.628. No abstract available.
PubMed 7606301
Study at a glance
From the registry record, last updated by the sponsor on 24 Mar 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Web-based Education on Oral Cancer for Primary Care Physicians in Ohio
- ClinicalTrials.gov ID
- NCT01424358
- Acronym / sponsor ID
- 11-16008
- Conditions
- Oral Cancer
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 10 participants (actual)
- Lead sponsor
- Creighton UniversityUniversity, hospital or other
- Collaborators
- National Institute of Dental and Craniofacial Research (NIDCR)
- Study start
- Jul 2011
- Primary completion
- Sep 2013 (actual)
- Study completion
- Sep 2013 (actual)
- First posted
- 29 Aug 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Objective:
The experimental design is a one-site, randomized experimental web-based educational feasibility intervention trial, with approximately 50% primary care physicians (PCPs) in the intervention group and approximately 50% PCPs on the control group, giving a total of 159 participants. All 159 participants have willingly provided their e-mail addresses, as part of a survey they previously completed entitled, "Survey of Health Professionals on Oral Cancer in Ohio- Intervention to Prevent Delayed Diagnosis of Oral Cancer."
Detailed description
The main specific aim is to determine the short-term effectiveness of a web-based educational intervention for primary care physicians (PCPs) in Ohio to improve the following:Index of knowledge of risk factors for oral cancer, and Index of knowledge of diagnostic procedures for oral cancer
The following hypothesis will be explored: The use of a web-based educational module for PCPs in Ohio regarding oral cancer will increase the proportion of the PCPs in the high score category for the following indices: Index of knowledge of risk factors of oral cancer, and Index of knowledge of diagnostic procedures for oral cancer
Study design
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Web-based Educational | Experimental | Other: Web-based Educational Intervention |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- The PCP's who participated in Specific Aim #2 (Survey of Healthcare Professionals on Oral Cancer in Ohio ) of the NIH K23 grant proposal, "Intervention to Prevent Delayed Diagnosis of Oral Cancer", will be eligible to participate in this Web-Based Education on Oral Cancer.
- Possessing the ability to give voluntary consent to participate. Participating in the web-based educational intervention is am implication of consent.
- All participants are expected to be relatively healthy.
Key exclusion criteria (1 listed)
- Unable to have access to the internet to be able to participate in the web-based education.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Web-based Educational InterventionThe intervention group will be invited to participate in the web-based educational program. PCPs in the intervention group will be asked to view the educational module which will be followed by an assessment. This group will be tested on the following knowledge outcomes: Index of knowledge of risk factor for oral cancer and Index of knowledge of diagnostic procedures for oral cancer. | Other | Web-based Educational |
Primary outcome
Index of knowledge of diagnostic procedure for oral cancer
Time frame: An average of 8 months from the time of the initial email sent on 7/21/11.
The list of participants will be sent an initial email inviting them to view the module and complete a pre test (control group) or a post test (intervention group). Reminder emails will be sent every 2 months for up to 6 months following the initial email. It is expected that at least a 15% higher proportion of Intervention group PCPs will attain the high score category for each of this index, as compared to the Control group PCPs.
2 secondary outcomes
To determine if a change in Stage of Diagnosis of Oral Cancer occurred for the particular year of Web-based Educational Intervention.
Time frame: 3 years
Index of knowledge of risk factors for oral cancer.
Time frame: An average of 8 months from the time of the initial email sent on 7/21/11.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Mar 2015.
- Background: PubMed 11814064Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002 Jan-Feb;52(1):23-47. doi: 10.3322/canjclin.52.1.23.
- Background: PubMed 12167440Canto MT, Devesa SS. Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998. Oral Oncol. 2002 Sep;38(6):610-7. doi: 10.1016/s1368-8375(01)00109-9.
- Background: PubMed 11803655Silverman S Jr. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc. 2001 Nov;132 Suppl:7S-11S. doi: 10.14219/jada.archive.2001.0382.
- Background: PubMed 100189Mashberg A, Garfinkel L. Early diagnosis of oral cancer: the erythroplastic lesion in high risk sites. CA Cancer J Clin. 1978 Sep-Oct;28(5):297-303. doi: 10.3322/canjclin.28.5.297. No abstract available.
- Background: PubMed 9089528Horowitz AM, Nourjah PA. Factors associated with having oral cancer examinations among US adults 40 years of age or older. J Public Health Dent. 1996 Fall;56(6):331-5. doi: 10.1111/j.1752-7325.1996.tb02460.x.
- Background: PubMed 12914834Canto MT, Drury TF, Horowitz AM. Use of skin and oral cancer examinations in the United States, 1998. Prev Med. 2003 Sep;37(3):278-82. doi: 10.1016/s0091-7435(03)00124-5.
- Background: PubMed 10390710Horowitz AM, Moon HS, Goodman HS, Yellowitz JA. Maryland adults' knowledge of oral cancer and having oral cancer examinations. J Public Health Dent. 1998 Fall;58(4):281-7. doi: 10.1111/j.1752-7325.1998.tb03010.x.
- Background: PubMed 7606301Goodman HS, Yellowitz JA, Horowitz AM. Oral cancer prevention. The role of family practitioners. Arch Fam Med. 1995 Jul;4(7):628-36. doi: 10.1001/archfami.4.7.628. No abstract available.
Related trials for Oral Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingPhase 2
Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial
Locally Advanced Oral Cavity Squamous Cell Carcinoma, Locally Recurrent Oral Cavity Squamous Cell Carcinoma
Active, not recruitingPhase 1/2
Study of Oral MRT-2359 in Selected Cancer Patients
NSCLC, SCLC
RecruitingPhase 1/2
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Active, not recruitingPhase 1
Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
Glioblastoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Alvin G Wee, DDS, MS, MPH principal investigator
Creighton University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Web-based Educational Intervention in people with Oral Cancer, run by Creighton University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Mar 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Index of knowledge of diagnostic procedure for oral cancer (time frame: An average of 8 months from the time of the initial email sent on 7/21/11.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01424358, which also lists 8 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2015.